Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20218875rdf:typepubmed:Citationlld:pubmed
pubmed-article:20218875lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20218875lifeskim:mentionsumls-concept:C1504389lld:lifeskim
pubmed-article:20218875lifeskim:mentionsumls-concept:C0009647lld:lifeskim
pubmed-article:20218875lifeskim:mentionsumls-concept:C0040557lld:lifeskim
pubmed-article:20218875lifeskim:mentionsumls-concept:C1515895lld:lifeskim
pubmed-article:20218875pubmed:issue8lld:pubmed
pubmed-article:20218875pubmed:dateCreated2010-3-17lld:pubmed
pubmed-article:20218875pubmed:abstractTextToxoplasmosis is an often fatal opportunistic infection following allogeneic hematopoietic stem cell transplantation and is largely due to deferred diagnosis. In addition, breakthrough infections occur during prophylaxis with trimethoprim-sulfamethoxazole.lld:pubmed
pubmed-article:20218875pubmed:languageenglld:pubmed
pubmed-article:20218875pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20218875pubmed:citationSubsetIMlld:pubmed
pubmed-article:20218875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20218875pubmed:statusMEDLINElld:pubmed
pubmed-article:20218875pubmed:monthAprlld:pubmed
pubmed-article:20218875pubmed:issn1537-6591lld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:DelforgeMiche...lld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:VerhoefGregor...lld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:MaertensJohan...lld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:DevosTimothyTlld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:TheunissenKoe...lld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:LagrouKatrien...lld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:MeerssemanWou...lld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:JanssensAnnAlld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:DierickxDaanDlld:pubmed
pubmed-article:20218875pubmed:authorpubmed-author:MeersStefSlld:pubmed
pubmed-article:20218875pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20218875pubmed:day15lld:pubmed
pubmed-article:20218875pubmed:volume50lld:pubmed
pubmed-article:20218875pubmed:ownerNLMlld:pubmed
pubmed-article:20218875pubmed:authorsCompleteYlld:pubmed
pubmed-article:20218875pubmed:pagination1127-34lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:meshHeadingpubmed-meshheading:20218875...lld:pubmed
pubmed-article:20218875pubmed:year2010lld:pubmed
pubmed-article:20218875pubmed:articleTitleMyeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.lld:pubmed
pubmed-article:20218875pubmed:affiliationHematology Department, University Hospitals Leuven, 3000 Leuven, Belgium. stef_meers@hotmail.comlld:pubmed
pubmed-article:20218875pubmed:publicationTypeJournal Articlelld:pubmed